Prosight Management, LP
- SEC CIK
- 0001617201
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/13 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 44
- 較 2021 年第 1 季 +7
- 總值
- $1.58 億
- 較 2021 年第 1 季 +$3,577 萬 (+29.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 422,000 | $2,170 萬 | 13.7% | −178,000−29.7% | 減碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 295,080 | $1,038 萬 | 6.6% | +124,728+73.2% | 加碼 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 137,000 | $934.3 萬 | 5.9% | +31,172+29.5% | 加碼 | 歷史 |
| HAEHaemonetics Corp | COM | 134,000 | $893.0 萬 | 5.7% | +134,000 | 新進 | 歷史 |
| CUECue Biopharma, Inc. | COM | 630,364 | $734.4 萬 | 4.7% | +73,587+13.2% | 加碼 | 歷史 |
| EHCEncompass Health Corp | COM | 88,000 | $686.7 萬 | 4.3% | −12,000−12.0% | 減碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 595,239 | $674.4 萬 | 4.3% | +121,793+25.7% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,023,704 | $555.9 萬 | 3.5% | +273,394+36.4% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 27,100 | $546.4 萬 | 3.5% | −11,250−29.3% | 減碼 | 歷史 |
| XCURExicure, Inc. | COM | 3,600,000 | $540.0 萬 | 3.4% | +3,324,152+1,205.1% | 加碼 | 歷史 |
| ZGNXZogenix, Inc. | COM NEW | 305,788 | $528.4 萬 | 3.3% | +110,788+56.8% | 加碼 | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 31,500 | $506.6 萬 | 3.2% | +10,303+48.6% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 72,000 | $496.0 萬 | 3.1% | +5,581+8.4% | 加碼 | 歷史 |
| CNVYConvey Health Solutions Holdings, Inc. | COM | 410,412 | $467.0 萬 | 3.0% | +410,412 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 181,171 | $434.1 萬 | 2.7% | +181,171 | 新進 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 273,523 | $424.0 萬 | 2.7% | −18,421−6.3% | 減碼 | 歷史 |
| RCMR1 RCM Holdco Inc. | COM | 171,817 | $382.1 萬 | 2.4% | +171,817 | 新進 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 64,292 | $369.0 萬 | 2.3% | +59,090+1,135.9% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 138,886 | $361.4 萬 | 2.3% | +138,886 | 新進 | 歷史 |
| MTCRMetacrine, Inc. | COM | 869,082 | $330.3 萬 | 2.1% | +564,597+185.4% | 加碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 420,000 | $283.1 萬 | 1.8% | −30,165−6.7% | 減碼 | 歷史 |
| QSIQuantum-Si Inc | COM CL A | 227,391 | $278.8 萬 | 1.8% | +227,391 | 新進 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 5,000 | $200.2 萬 | 1.3% | −1,000−16.7% | 減碼 | 歷史 |
| LHCGLHC Group, Inc | COM | 9,888 | $198.0 萬 | 1.3% | +1,105+12.6% | 加碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 130,000 | $168.5 萬 | 1.1% | −230,834−64.0% | 減碼 | 歷史 |
| ATIPATI Physical Therapy, Inc. | COM CL A | 173,276 | $165.3 萬 | 1.0% | +173,276 | 新進 | 歷史 |
| MDTMedtronic plc | Stock | 11,000 | $136.5 萬 | 0.9% | −9,088−45.2% | 減碼 | 歷史 |
| IRTCiRhythm Holdings, Inc. | COM | 20,200 | $134.0 萬 | 0.8% | +20,200 | 新進 | 歷史 |
| CLLSCellectis S.A. | SPON ADS | 86,036 | $133.1 萬 | 0.8% | −51,864−37.6% | 減碼 | 歷史 |
| OSCROscar Health, Inc. | CL A | 55,000 | $118.2 萬 | 0.7% | −52,086−48.6% | 減碼 | 歷史 |
| EVHEvolent Health, Inc. | CL A | 52,023 | $109.9 萬 | 0.7% | +52,023 | 新進 | 歷史 |
| CLOVClover Health Investments, Corp. | COM CL A | 79,100 | $105.4 萬 | 0.7% | +79,100 | 新進 | 歷史 |
| AKUAkumin Inc. | COM | 327,680 | $103.2 萬 | 0.7% | −101,381−23.6% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 91,694 | $85.4 萬 | 0.5% | +91,694 | 新進 | 歷史 |
| SIOXSio Gene Therapies Inc. | COMMON | 256,115 | $69.9 萬 | 0.4% | +50,215+24.4% | 加碼 | 歷史 |
| ONCROncorus, Inc. | COM | 50,000 | $69.0 萬 | 0.4% | −20,807−29.4% | 減碼 | 歷史 |
| OPCHOption Care Health, Inc. | COM NEW | 27,875 | $61.0 萬 | 0.4% | +27,875 | 新進 | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 149,090 | $57.8 萬 | 0.4% | +92,590+163.9% | 加碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 87,813 | $57.1 萬 | 0.4% | +87,813 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 54,934 | $51.3 萬 | 0.3% | +54,934 | 新進 | 歷史 |
| APTOAptose Biosciences Inc. | COM NEW | 133,000 | $44.2 萬 | 0.3% | −17,000−11.3% | 減碼 | 歷史 |
| ORGOOrganogenesis Holdings Inc. | COM | 25,100 | $41.7 萬 | 0.3% | +9,868+64.8% | 加碼 | 歷史 |
| CANOCano Health, Inc. | COM CL A | 23,200 | $28.1 萬 | 0.2% | +23,200 | 新進 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 115,100 | $18.4 萬 | 0.1% | −382,742−76.9% | 減碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Albireo Pharma Inc01345P906 | CALL | – | $115.7 萬 |
| Aurinia Pharmaceuticals Inc05156V902 | CALL | – | $87.1 萬 |
2021 年第 1 季之後清倉（8 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 95,600 | $603.5 萬 | 4.9% | 歷史 |
| INOVInovalon Holdings, Inc. | COM CL A | 85,000 | $244.6 萬 | 2.0% | 歷史 |
| TVRDTvardi Therapeutics, Inc. | COM | 100,000 | $217.1 萬 | 1.8% | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 320,100 | $177.0 萬 | 1.4% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 17,000 | $136.1 萬 | 1.1% | 歷史 |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 8,685 | $132.8 萬 | 1.1% | 歷史 |
| BAXBaxter International Inc | Stock | 5,800 | $48.9 萬 | 0.4% | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 117,621 | $40.2 萬 | 0.3% | 歷史 |